The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma

Misako Shibamoto, Hidenari Hirata, Hidetoshi Eguchi, Genta Sawada, Noritaka Sakai, Yoshiaki Kajiyama, Koshi Mimori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Esophageal squamous cell carcinoma (ESCC) has high biological malignant potential among the various digestive tract cancers and is associated with a poor prognosis. To identify novel genes involved in tumor progression, the present study analyzed the genetic and transcriptional alterations in two clinical cohorts, totaling 157cases of ESCC (78cases from the discovery set and 79cases from the validation set). From the discovery set, gene expression and copy number profiles were analyzed using expression arrays and array-comparative genomic hybridization, respectively. Notably, a copy number loss of caspase-4 (CASP4) was observed in 82% of ESCC cases and CASP4 expression levels were significantly associated with copy number levels. Gene set enrichment analysis demonstrated that the upregulation of CASP4 expression levels was associated with the signaling pathways involved in apoptosis, inflammatory responses and immune responses. The present study demonstrated that CASP4 expression levels were significantly associated with the expression levels of the endoplasmic reticulum (ER) stress marker glucose-regulated protein 78, indicating that CASP4 has a role in cell death induced by ER stress in ESCC. In the survival analysis the CASP4 low expression group exhibited a poor prognosis, compared with the CASP4 high expression group in the discovery set (P=0.003); this observation was reproduced in the validation set (P=0.037). Therefore, the results of the current study suggest that CASP4 may function as a tumor-suppressor gene and may have applications as a biomarker for the prediction of the prognosis in ESCC.

Original languageEnglish
Pages (from-to)1761-1766
Number of pages6
JournalOncology Letters
Volume13
Issue number3
DOIs
Publication statusPublished - Mar 2017

Fingerprint

Caspases
Endoplasmic Reticulum Stress
Comparative Genomic Hybridization
Gene Dosage
Esophageal Squamous Cell Carcinoma
Survival Analysis
Tumor Suppressor Genes
Genes
Gastrointestinal Tract
Neoplasms
Cell Death
Up-Regulation
Biomarkers
Gene Expression

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma. / Shibamoto, Misako; Hirata, Hidenari; Eguchi, Hidetoshi; Sawada, Genta; Sakai, Noritaka; Kajiyama, Yoshiaki; Mimori, Koshi.

In: Oncology Letters, Vol. 13, No. 3, 03.2017, p. 1761-1766.

Research output: Contribution to journalArticle

Shibamoto, M, Hirata, H, Eguchi, H, Sawada, G, Sakai, N, Kajiyama, Y & Mimori, K 2017, 'The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma', Oncology Letters, vol. 13, no. 3, pp. 1761-1766. https://doi.org/10.3892/ol.2017.5646
Shibamoto, Misako ; Hirata, Hidenari ; Eguchi, Hidetoshi ; Sawada, Genta ; Sakai, Noritaka ; Kajiyama, Yoshiaki ; Mimori, Koshi. / The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma. In: Oncology Letters. 2017 ; Vol. 13, No. 3. pp. 1761-1766.
@article{21e19f6c5bac4a468e948cd5399132f6,
title = "The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma",
abstract = "Esophageal squamous cell carcinoma (ESCC) has high biological malignant potential among the various digestive tract cancers and is associated with a poor prognosis. To identify novel genes involved in tumor progression, the present study analyzed the genetic and transcriptional alterations in two clinical cohorts, totaling 157cases of ESCC (78cases from the discovery set and 79cases from the validation set). From the discovery set, gene expression and copy number profiles were analyzed using expression arrays and array-comparative genomic hybridization, respectively. Notably, a copy number loss of caspase-4 (CASP4) was observed in 82{\%} of ESCC cases and CASP4 expression levels were significantly associated with copy number levels. Gene set enrichment analysis demonstrated that the upregulation of CASP4 expression levels was associated with the signaling pathways involved in apoptosis, inflammatory responses and immune responses. The present study demonstrated that CASP4 expression levels were significantly associated with the expression levels of the endoplasmic reticulum (ER) stress marker glucose-regulated protein 78, indicating that CASP4 has a role in cell death induced by ER stress in ESCC. In the survival analysis the CASP4 low expression group exhibited a poor prognosis, compared with the CASP4 high expression group in the discovery set (P=0.003); this observation was reproduced in the validation set (P=0.037). Therefore, the results of the current study suggest that CASP4 may function as a tumor-suppressor gene and may have applications as a biomarker for the prediction of the prognosis in ESCC.",
author = "Misako Shibamoto and Hidenari Hirata and Hidetoshi Eguchi and Genta Sawada and Noritaka Sakai and Yoshiaki Kajiyama and Koshi Mimori",
year = "2017",
month = "3",
doi = "10.3892/ol.2017.5646",
language = "English",
volume = "13",
pages = "1761--1766",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma

AU - Shibamoto, Misako

AU - Hirata, Hidenari

AU - Eguchi, Hidetoshi

AU - Sawada, Genta

AU - Sakai, Noritaka

AU - Kajiyama, Yoshiaki

AU - Mimori, Koshi

PY - 2017/3

Y1 - 2017/3

N2 - Esophageal squamous cell carcinoma (ESCC) has high biological malignant potential among the various digestive tract cancers and is associated with a poor prognosis. To identify novel genes involved in tumor progression, the present study analyzed the genetic and transcriptional alterations in two clinical cohorts, totaling 157cases of ESCC (78cases from the discovery set and 79cases from the validation set). From the discovery set, gene expression and copy number profiles were analyzed using expression arrays and array-comparative genomic hybridization, respectively. Notably, a copy number loss of caspase-4 (CASP4) was observed in 82% of ESCC cases and CASP4 expression levels were significantly associated with copy number levels. Gene set enrichment analysis demonstrated that the upregulation of CASP4 expression levels was associated with the signaling pathways involved in apoptosis, inflammatory responses and immune responses. The present study demonstrated that CASP4 expression levels were significantly associated with the expression levels of the endoplasmic reticulum (ER) stress marker glucose-regulated protein 78, indicating that CASP4 has a role in cell death induced by ER stress in ESCC. In the survival analysis the CASP4 low expression group exhibited a poor prognosis, compared with the CASP4 high expression group in the discovery set (P=0.003); this observation was reproduced in the validation set (P=0.037). Therefore, the results of the current study suggest that CASP4 may function as a tumor-suppressor gene and may have applications as a biomarker for the prediction of the prognosis in ESCC.

AB - Esophageal squamous cell carcinoma (ESCC) has high biological malignant potential among the various digestive tract cancers and is associated with a poor prognosis. To identify novel genes involved in tumor progression, the present study analyzed the genetic and transcriptional alterations in two clinical cohorts, totaling 157cases of ESCC (78cases from the discovery set and 79cases from the validation set). From the discovery set, gene expression and copy number profiles were analyzed using expression arrays and array-comparative genomic hybridization, respectively. Notably, a copy number loss of caspase-4 (CASP4) was observed in 82% of ESCC cases and CASP4 expression levels were significantly associated with copy number levels. Gene set enrichment analysis demonstrated that the upregulation of CASP4 expression levels was associated with the signaling pathways involved in apoptosis, inflammatory responses and immune responses. The present study demonstrated that CASP4 expression levels were significantly associated with the expression levels of the endoplasmic reticulum (ER) stress marker glucose-regulated protein 78, indicating that CASP4 has a role in cell death induced by ER stress in ESCC. In the survival analysis the CASP4 low expression group exhibited a poor prognosis, compared with the CASP4 high expression group in the discovery set (P=0.003); this observation was reproduced in the validation set (P=0.037). Therefore, the results of the current study suggest that CASP4 may function as a tumor-suppressor gene and may have applications as a biomarker for the prediction of the prognosis in ESCC.

UR - http://www.scopus.com/inward/record.url?scp=85011920498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011920498&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.5646

DO - 10.3892/ol.2017.5646

M3 - Article

AN - SCOPUS:85011920498

VL - 13

SP - 1761

EP - 1766

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 3

ER -